Quality

The focus of quality improvement in healthcare is to bolster performance and processes related to diagnostic and therapeutic procedures. Leaders in this space also ensure the proper selection of imaging exams and procedures, and monitor the safety of services, among other duties. Reimbursement programs such as the Merit-based Incentive Payment System (MIPS) utilize financial incentives to improve quality. This also includes setting and maintaining care quality initiatives, such as the requirements set by the Joint Commission.

CMS quality changes signal continued interest in comparing hospital outpatient and ambulatory surgical centers

Low-risk procedures performed in a hospital outpatient setting are reimbursed at a higher level than the same procedures performed in an ambulatory surgery center (ASC), but is there value in the higer payments for procedures done in hospital outpatient surgical departments? In proposed quality measure changes, the Centers for Medicare and Medicaid Services (CMS) aims to make it easier to compare quality between the two types of surgical settings.

Thumbnail

Study lends support to targeted interventions in erasing cancer screening disparities

Being poor raises the risk of dying from cancer considerably for many reasons, not the least of which is the disparity in cancer screening rates between rich and poor. A new study appearing in JAMA Internal Medicine adds research support to the importance of targeted interventions in erasing such disparities.

Leading treatment centers and patient group form alliance to improve AFib care

Five heart treatment centers in four states, along with an atrial fibrillation (AFib) patient advocacy group have formed a national alliance to improve arrhythmia treatment by sharing information on best practices, creating better care standards and gathering outcome information.

Thumbnail

Hawaiian hospital’s pediatric asthma initiative cuts readmission rates

For a study appearing in Pediatrics, researchers took a look at the outcome measures of the Asthma Task Force changes implemented at the Kapi'olani Medical Center for Women and Children and University of Hawaii John A. Burns School of Medicine in Honolulu, Hawaii. They found that yes, not surprisingly, better patient adherence to treatment plans correlated with a significant reduction in readmission rates.

Thumbnail

Premier analysis finds Medicare tracking of hospital-acquired conditions insufficient

Creating an accurate system for evaluating hospital quality for payments, as well as spotting areas where savings could be achieved and deaths prevented, is becoming increasingly important to health system leaders. However, the current list of hospital-acquired conditions (HACs) that Medicare uses to set payments for hospitals, may be too narrow finds an analysis of discharge codes conducted by the Premier Inc. healthcare alliance.

Thumbnail

State Hospital Engagement Network saves $446 million and 46,112 patients from harm

Reductions in falls, infections, adverse drug events, and other patient harm at hospitals participating in the Pennsylvania Hospital Engagement Network (PA-HEN) are collectively making a big impact on both health care spending and patient outcomes in the state says the Hospital and Healthsystem Association of Pennsylvania.

Thumbnail

Joint Commission counted 887 sentinel events in 2013

Among the 887 sentinel events the Joint Commission recorded last year, the top three were delays in treatment that resulted in death or permanent disability; wrong-site, wrong-patient or wrong-procedure mistakes; and unintended retention of a foreign object after a procedure.

Thumbnail

Three out of four medical directors now say their duties are tied to patient-satisfaction and care-quality metrics

According to the Medical Group Management Association (MGMA) Medical Directorship Compensation Survey, last year, more than 75 percent of the 1,621 medical directors that participated in the survey said their duties were specifically tied to patient-satisfaction and quality-of-care numbers. In addition, more than 35 percent reported that their duties were tied to patient safety metrics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.